Arch Therapeutics, Inc.
Arch Therapeutics, Inc. (ARTH) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ARTH · as of Jun 9, 2026
Key Statistics
Explore Arch Therapeutics, Inc. Data
arth stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 100.0%
Competitors & Peers
arth competitorsARTH
ACGJ
ALNAQ
BLEVF
IMVIQ
MDKMStock Performance
Full HistoryAbout Arch Therapeutics, Inc.
Arch Therapeutics, Inc. operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products d…
what is arch therapeutics, inc. · arth stock overview · arch therapeutics, inc. company profile · who is arch therapeutics, inc. ceo · arth OTC · arch therapeutics, inc. headquarters · arch therapeutics, inc. business segments
About Stock Overview & Key Data
Arch Therapeutics, Inc. (ARTH) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 2, 2013. As of the latest trading session, ARTH stock price is $0.00, with a market capitalization of $444. The stock has returned -99.99% over the past 12 months and -99.95% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Arch Therapeutics, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2023, Arch Therapeutics, Inc. reported revenue of $75724.00 and net income of -$7.0M. For detailed data — including Arch Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Arch Therapeutics, Inc. (ARTH) stock price is $0.00. The stock is traded on OTC under the ticker symbol ARTH. The 52-week range is $0.00 – $1.57.